Evergreen Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Bethesda MD United States (2019)

Organization Overview

First Clinical Trial
2019
NCT03527472
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Evergreen Therapeutics, Inc.